Report Detail

Other Global Oral Migraine Drugs Market Growth (Status and Outlook) 2022-2028

  • RnM4495328
  • |
  • 18 November, 2022
  • |
  • Global
  • |
  • 87 Pages
  • |
  • LPI(LP Information)
  • |
  • Other

The global market for Oral Migraine Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Oral Migraine Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Oral Migraine Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Oral Migraine Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Oral Migraine Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Oral Migraine Drugs players cover GSK, Teva, Pfizer, Novartis and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Oral Migraine Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Oral Migraine Drugs market, with both quantitative and qualitative data, to help readers understand how the Oral Migraine Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Oral Migraine Drugs market and forecasts the market size by Type (Prescription Drug and OTC Drug,), by Application (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Prescription Drug
OTC Drug

Segmentation by application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J

Chapter Introduction
Chapter 1: Scope of Oral Migraine Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Oral Migraine Drugs market size and CAGR, Oral Migraine Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Oral Migraine Drugs revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Oral Migraine Drugs revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Oral Migraine Drugs market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including GSK, Teva, Pfizer, Novartis, Sun Pharma, Grunenthal, Endo Pharmaceuticals, Merck and J & J, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Oral Migraine Drugs Market Size 2017-2028
    • 2.1.2 Oral Migraine Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Oral Migraine Drugs Segment by Type
    • 2.2.1 Prescription Drug
    • 2.2.2 OTC Drug
  • 2.3 Oral Migraine Drugs Market Size by Type
    • 2.3.1 Oral Migraine Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Oral Migraine Drugs Market Size Market Share by Type (2017-2022)
  • 2.4 Oral Migraine Drugs Segment by Application
    • 2.4.1 Hospital Pharmacy
    • 2.4.2 Retail Pharmacy
    • 2.4.3 Online Pharmacy
  • 2.5 Oral Migraine Drugs Market Size by Application
    • 2.5.1 Oral Migraine Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Oral Migraine Drugs Market Size Market Share by Application (2017-2022)

3 Oral Migraine Drugs Market Size by Player

  • 3.1 Oral Migraine Drugs Market Size Market Share by Players
    • 3.1.1 Global Oral Migraine Drugs Revenue by Players (2020-2022)
    • 3.1.2 Global Oral Migraine Drugs Revenue Market Share by Players (2020-2022)
  • 3.2 Global Oral Migraine Drugs Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Oral Migraine Drugs by Regions

  • 4.1 Oral Migraine Drugs Market Size by Regions (2017-2022)
  • 4.2 Americas Oral Migraine Drugs Market Size Growth (2017-2022)
  • 4.3 APAC Oral Migraine Drugs Market Size Growth (2017-2022)
  • 4.4 Europe Oral Migraine Drugs Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Oral Migraine Drugs Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Oral Migraine Drugs Market Size by Country (2017-2022)
  • 5.2 Americas Oral Migraine Drugs Market Size by Type (2017-2022)
  • 5.3 Americas Oral Migraine Drugs Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Oral Migraine Drugs Market Size by Region (2017-2022)
  • 6.2 APAC Oral Migraine Drugs Market Size by Type (2017-2022)
  • 6.3 APAC Oral Migraine Drugs Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Oral Migraine Drugs by Country (2017-2022)
  • 7.2 Europe Oral Migraine Drugs Market Size by Type (2017-2022)
  • 7.3 Europe Oral Migraine Drugs Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Oral Migraine Drugs by Region (2017-2022)
  • 8.2 Middle East & Africa Oral Migraine Drugs Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Oral Migraine Drugs Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Oral Migraine Drugs Market Forecast

  • 10.1 Global Oral Migraine Drugs Forecast by Regions (2023-2028)
    • 10.1.1 Global Oral Migraine Drugs Forecast by Regions (2023-2028)
    • 10.1.2 Americas Oral Migraine Drugs Forecast
    • 10.1.3 APAC Oral Migraine Drugs Forecast
    • 10.1.4 Europe Oral Migraine Drugs Forecast
    • 10.1.5 Middle East & Africa Oral Migraine Drugs Forecast
  • 10.2 Americas Oral Migraine Drugs Forecast by Country (2023-2028)
    • 10.2.1 United States Oral Migraine Drugs Market Forecast
    • 10.2.2 Canada Oral Migraine Drugs Market Forecast
    • 10.2.3 Mexico Oral Migraine Drugs Market Forecast
    • 10.2.4 Brazil Oral Migraine Drugs Market Forecast
  • 10.3 APAC Oral Migraine Drugs Forecast by Region (2023-2028)
    • 10.3.1 China Oral Migraine Drugs Market Forecast
    • 10.3.2 Japan Oral Migraine Drugs Market Forecast
    • 10.3.3 Korea Oral Migraine Drugs Market Forecast
    • 10.3.4 Southeast Asia Oral Migraine Drugs Market Forecast
    • 10.3.5 India Oral Migraine Drugs Market Forecast
    • 10.3.6 Australia Oral Migraine Drugs Market Forecast
  • 10.4 Europe Oral Migraine Drugs Forecast by Country (2023-2028)
    • 10.4.1 Germany Oral Migraine Drugs Market Forecast
    • 10.4.2 France Oral Migraine Drugs Market Forecast
    • 10.4.3 UK Oral Migraine Drugs Market Forecast
    • 10.4.4 Italy Oral Migraine Drugs Market Forecast
    • 10.4.5 Russia Oral Migraine Drugs Market Forecast
  • 10.5 Middle East & Africa Oral Migraine Drugs Forecast by Region (2023-2028)
    • 10.5.1 Egypt Oral Migraine Drugs Market Forecast
    • 10.5.2 South Africa Oral Migraine Drugs Market Forecast
    • 10.5.3 Israel Oral Migraine Drugs Market Forecast
    • 10.5.4 Turkey Oral Migraine Drugs Market Forecast
    • 10.5.5 GCC Countries Oral Migraine Drugs Market Forecast
  • 10.6 Global Oral Migraine Drugs Forecast by Type (2023-2028)
  • 10.7 Global Oral Migraine Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 GSK
    • 11.1.1 GSK Company Information
    • 11.1.2 GSK Oral Migraine Drugs Product Offered
    • 11.1.3 GSK Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 GSK Main Business Overview
    • 11.1.5 GSK Latest Developments
  • 11.2 Teva
    • 11.2.1 Teva Company Information
    • 11.2.2 Teva Oral Migraine Drugs Product Offered
    • 11.2.3 Teva Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Teva Main Business Overview
    • 11.2.5 Teva Latest Developments
  • 11.3 Pfizer
    • 11.3.1 Pfizer Company Information
    • 11.3.2 Pfizer Oral Migraine Drugs Product Offered
    • 11.3.3 Pfizer Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Pfizer Main Business Overview
    • 11.3.5 Pfizer Latest Developments
  • 11.4 Novartis
    • 11.4.1 Novartis Company Information
    • 11.4.2 Novartis Oral Migraine Drugs Product Offered
    • 11.4.3 Novartis Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Novartis Main Business Overview
    • 11.4.5 Novartis Latest Developments
  • 11.5 Sun Pharma
    • 11.5.1 Sun Pharma Company Information
    • 11.5.2 Sun Pharma Oral Migraine Drugs Product Offered
    • 11.5.3 Sun Pharma Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Sun Pharma Main Business Overview
    • 11.5.5 Sun Pharma Latest Developments
  • 11.6 Grunenthal
    • 11.6.1 Grunenthal Company Information
    • 11.6.2 Grunenthal Oral Migraine Drugs Product Offered
    • 11.6.3 Grunenthal Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 Grunenthal Main Business Overview
    • 11.6.5 Grunenthal Latest Developments
  • 11.7 Endo Pharmaceuticals
    • 11.7.1 Endo Pharmaceuticals Company Information
    • 11.7.2 Endo Pharmaceuticals Oral Migraine Drugs Product Offered
    • 11.7.3 Endo Pharmaceuticals Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Endo Pharmaceuticals Main Business Overview
    • 11.7.5 Endo Pharmaceuticals Latest Developments
  • 11.8 Merck
    • 11.8.1 Merck Company Information
    • 11.8.2 Merck Oral Migraine Drugs Product Offered
    • 11.8.3 Merck Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Merck Main Business Overview
    • 11.8.5 Merck Latest Developments
  • 11.9 J & J
    • 11.9.1 J & J Company Information
    • 11.9.2 J & J Oral Migraine Drugs Product Offered
    • 11.9.3 J & J Oral Migraine Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 J & J Main Business Overview
    • 11.9.5 J & J Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Oral Migraine Drugs. Industry analysis & Market Report on Oral Migraine Drugs is a syndicated market report, published as Global Oral Migraine Drugs Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Oral Migraine Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,997.54
5,995.08
3,484.32
6,968.64
498,455.40
996,910.80
298,948.80
597,897.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report